BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10571063)

  • 1. Engineering an unnatural Nalpha-anchored disulfide into BPTI by total chemical synthesis: structural and functional consequences.
    Bark SJ; Kent SB
    FEBS Lett; 1999 Oct; 460(1):67-76. PubMed ID: 10571063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure of single-disulfide variants of bovine pancreatic trypsin inhibitor (BPTI) as probed by their binding to bovine beta-trypsin.
    Krokoszynska I; Dadlez M; Otlewski J
    J Mol Biol; 1998 Jan; 275(3):503-13. PubMed ID: 9466927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of backbone dynamics in native BPTI: cooperative influence of the 14-38 disulfide and the Tyr35 side-chain.
    Beeser SA; Oas TG; Goldenberg DP
    J Mol Biol; 1998 Dec; 284(5):1581-96. PubMed ID: 9878372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total chemical synthesis of bovine pancreatic trypsin inhibitor by native chemical ligation.
    Lu W; Starovasnik MA; Kent SB
    FEBS Lett; 1998 Jun; 429(1):31-5. PubMed ID: 9657378
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Secretion efficiency in Saccharomyces cerevisiae of bovine pancreatic trypsin inhibitor mutants lacking disulfide bonds is correlated with thermodynamic stability.
    Kowalski JM; Parekh RN; Wittrup KD
    Biochemistry; 1998 Feb; 37(5):1264-73. PubMed ID: 9477952
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On the biosynthesis of bovine pancreatic trypsin inhibitor (BPTI). Structure, processing, folding and disulphide bond formation of the precursor in vitro and in microsomes.
    Creighton TE; Bagley CJ; Cooper L; Darby NJ; Freedman RB; Kemmink J; Sheikh A
    J Mol Biol; 1993 Aug; 232(4):1176-96. PubMed ID: 7690407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between disulfide reduction and conformational unfolding in bovine pancreatic trypsin inhibitor.
    Ma LC; Anderson S
    Biochemistry; 1997 Mar; 36(12):3728-36. PubMed ID: 9132026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Partially folded conformation of the (30-51) intermediate in the disulphide folding pathway of bovine pancreatic trypsin inhibitor. 1H and 15N resonance assignments and determination of backbone dynamics from 15N relaxation measurements.
    van Mierlo CP; Darby NJ; Keeler J; Neuhaus D; Creighton TE
    J Mol Biol; 1993 Feb; 229(4):1125-46. PubMed ID: 7680380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid formation of the native 14-38 disulfide bond in the early stages of BPTI folding.
    Dadlez M; Kim PS
    Biochemistry; 1996 Dec; 35(50):16153-64. PubMed ID: 8973187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution structure of bovine pancreatic trypsin inhibitor with altered binding loop sequence.
    Czapinska H; Otlewski J; Krzywda S; Sheldrick GM; Jaskólski M
    J Mol Biol; 2000 Feb; 295(5):1237-49. PubMed ID: 10653700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of human leukocyte and porcine pancreatic elastase by homologues of bovine pancreatic trypsin inhibitor.
    Kraunsoe JA; Claridge TD; Lowe G
    Biochemistry; 1996 Jul; 35(28):9090-6. PubMed ID: 8703913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unfolded BPTI variants with a single disulfide bond have diminished non-native structure distant from the crosslink.
    Barbar E; Barany G; Woodward C
    Fold Des; 1996; 1(1):65-76. PubMed ID: 9079365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (13)C-NMR studies on disulfide bond isomerization in bovine pancreatic trypsin inhibitor (BPTI).
    Takeda M; Miyanoiri Y; Terauchi T; Kainosho M
    J Biomol NMR; 2016 Sep; 66(1):37-53. PubMed ID: 27566173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solid-phase synthesis of bovine pancreatic trypsin inhibitor (BPTI) and two analogues. A chemical approach for evaluating the role of disulfide bridges in protein folding and stability.
    Ferrer M; Woodward C; Barany G
    Int J Pept Protein Res; 1992; 40(3-4):194-207. PubMed ID: 1282503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (14-38, 30-51) double-disulphide intermediate in folding of bovine pancreatic trypsin inhibitor: a two-dimensional 1H nuclear magnetic resonance study.
    van Mierlo CP; Darby NJ; Neuhaus D; Creighton TE
    J Mol Biol; 1991 Nov; 222(2):353-71. PubMed ID: 1960731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insight into the factors influencing the backbone dynamics of three homologous proteins, dendrotoxins I and K, and BPTI: FTIR and time-resolved fluorescence investigations.
    Hollecker M; Vincent M; Gallay J; Ruysschaert JM; Goormaghtigh E
    Biochemistry; 2002 Dec; 41(51):15267-76. PubMed ID: 12484765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the (30-51, 14-38) two-disulphide folding intermediates of the homologous proteins dendrotoxin K and bovine pancreatic trypsin inhibitor by two-dimensional 1H nuclear magnetic resonance.
    Kortemme T; Hollecker M; Kemmink J; Creighton TE
    J Mol Biol; 1996 Mar; 257(1):188-98. PubMed ID: 8632454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain,
    Sorensen MD; Bjorn S; Norris K; Olsen O; Petersen L; James TL; Led JJ
    Biochemistry; 1997 Aug; 36(34):10439-50. PubMed ID: 9265624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folding of bovine pancreatic trypsin inhibitor (BPTI) variants in which almost half the residues are alanine.
    Kuroda Y; Kim PS
    J Mol Biol; 2000 May; 298(3):493-501. PubMed ID: 10772865
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The structure of denatured bovine pancreatic trypsin inhibitor (BPTI).
    Chang J; Ballatore A
    FEBS Lett; 2000 May; 473(2):183-7. PubMed ID: 10812071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.